Drug firm Strides Pharma Science said its step down subsidiary Strides Pharma Global, Singapore (SPG) has entered into a joint venture with Sun Moral International, a wholly-owned subsidiary of China’s Sihuan Pharmaceutical Holdings Group, one of Chinas leading pharmaceutical companies. Both the companies will set up a JV company based in Hong Kong to be christened as Sihuan Strides HK, where SPG will own 49 per cent stake, Strides Pharma said in a statement. The JV fast tracks Strides’ entry into China, the second-largest pharmaceutical market in the world with a USD 137 billion market opportunity.